Coronary thrombosis and myocardial ischemia in Kawasaki disease: a case report
This case suggests that for patients at high risk of coronary artery aneurysms, echocardiography may need to be reviewed earlier. Low-molecular-weight heparin should be added to antagonize the early procoagulant effects of warfarin when warfarin therapy is initiated. In the case of first-detected coronary thrombosis, aggressive thrombolytic therapy may be justified, particularly during the acute and subacute phases of the disease course.
Authors
- Chunhong Xie
- Qing Zhang (ORCID: https://orcid.org/0000-0003-3522-1471)
- Songling Fu
- Xiaofeng Wang (ORCID: https://orcid.org/0000-0002-8916-5404)
- Yiying Zhang (ORCID: https://orcid.org/0000-0001-9965-2276)
- Jian Hu
- Fangqi Gong (ORCID: https://orcid.org/0000-0003-2081-096X)
- Lichao Gao
Institutions
- Children's Hospital of Zhejiang University (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s12872-024-04148-8
- Citations
- 2
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- National Natural Science Foundation of China
- Zhejiang University